| |
|
|
|
La Jolla Pharmaceutical Company  
|
|
10.31 0.35 (0.04%) |
08-21 16:00 |
|
Open: |
9.91 |
Pre close: |
9.96 |
Target:
|
12.12
|
|
High: |
10.35 |
Low: |
9.82 |
Resistance:
|
10.38
12.12
|
|
Volume: |
313,625 |
Market Cap: |
280M |
Support:
|
8.76
7.76
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
9.88
 |
MACD |
MACD(12,26):
|
0.34 |
|
MA(20): |
8.91 |
Signal(12,26,9): |
0.17 |
|
MA(100): |
8.09 |
Stochastic Oscillator |
%K(14,3):
|
88.42 |
|
MA(250): |
10.90  |
%D(3): |
85.58 |
|
Average Volume(K) |
3-Month: |
126659
|
52-Week |
High:
|
24.24 |
|
10-Days: |
37154 |
Low: |
5.01 |
|
RSI |
RSI(14):
|
72.85 |
Change(%): |
-56.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-5.920 |
Return on Equity (ttm) |
-307.1 |
Shares Out. (M) |
27.08 |
|
EPS Est. Current Year |
-4.990 |
Return on Assets (ttm) |
-40.9 |
Shares Float (M) |
14.89 |
|
EPS Est. Next Year |
-3.970 |
PEG Ratio |
-0.16 |
% Held by Insiders |
6.08 |
|
EPS Est. Next Quarter |
-1.420 |
Qtrly Rev. Growth |
258.0 |
% Held by Institutions |
104.64 |
|
Forward EPS |
-2.611 |
Gross Profit (p.s.) |
-3.932 |
Shares Short (K) |
6040 |
|
Book Value (p.s.) |
-0.610 |
EBITDA (p.s.) |
-5.181 |
P/E |
-1.74 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-16.90 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-118.15 |
P/S |
423022432.00 |
|
Operating Margin |
-816.09 |
Levered Free Cash Flow
(M) |
-60.74 |
P/CF |
-2.36 |
|
|
|
|
|
|
